M&AHealthcareSIGNED
Cinven to acquire Theramex for €2.6bn from Carlyle and PAI Partners
Value
€2.6Bn
Acquirer
Cinven
Target
Theramex
Cinven has agreed to buy women's health and menopause specialist Theramex from Carlyle and PAI Partners for €2.6bn. The transaction values the business at more than double what the selling private equity firms paid four years ago.
✦ Meridian Analysis
Cinven has signed a €2.6 billion transaction to acquire Theramex, a specialist in women’s health and menopause, from Carlyle and PAI Partners.
The transaction value represents more than double the price paid by the private‑equity owners four years ago.
A deal of this size typically combines equity from the buyer with a debt component, often arranged through senior secured loans or a syndicated facility.
The Meridian Weekly
The week's largest deals and the Iberian ones, every Monday. Free.